Coby Health vs Willow
$239/mo against $399/mo for tirzepatide. Which is worth it, and for whom.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
Both sell tirzepatide. Coby Health costs $239 a month and Willow costs $399, a difference of $160 a month or about $1,920 a year. The desk reads it as follows.
Coby Health is multi-month value with supplies included. Willow is straightforward single-price plans. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.
Advert against bill. Coby Health advertises $179 and bills $239; Willow advertises $399 and bills $399. The gaps are different sizes, which means comparing the two on their advertised prices gives you the wrong answer.
Side by side
| Coby Health | Willow | |
|---|---|---|
| Advertised from | $179 | $399 |
| Membership on top | None | None |
| True monthly cost | $239 | $399 |
| Roughly, per year | $2,868 | $4,788 |
| Price includes medication | Yes | Yes |
| Names its pharmacy | Not published | Not published |
| Our score | 3.6 / 5 | 2.9 / 5 |
Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.
The split
On every attribute we track these two behave identically — same answer on dose pricing, commitment, pharmacy disclosure, formats, insurance and what the price includes. When that happens the decision really is just the monthly figure, and Coby Health is $160 a month cheaper.
What each puts on the record: Coby Health
- Compounded tirzepatide listed at $239/month on the monthly plan, down from $299.
- Multi-month plans bring compounded tirzepatide to about $179/month.
- An at-home injection kit with alcohol pads and syringes is included.
- Monthly plans can be cancelled at any time.
- States plainly on its own product pages that compounded medication is not FDA-reviewed or approved.
Where it wins: Injection supplies are included rather than something you source yourself. Watch for: The $179 figure is a multi-month rate. Month-to-month is $239.
What each puts on the record: Willow
- Compounded tirzepatide listed at $399/month.
Where it wins: A single price with no membership arithmetic. Watch for: There is little published detail on how dose changes are handled. Ask before committing.
In each one’s favour
Coby Health.
- Injection supplies are included rather than something you source yourself.
- Monthly plan is genuinely cancel-anytime.
Willow.
- A single price with no membership arithmetic.
How they score
| What we weigh | Weight | Coby | Willow |
|---|---|---|---|
| True monthly cost | 30% | 3.7 | 2.4 |
| Price honesty | 20% | 3.6 | 3 |
| Clinical support | 20% | 3.3 | 3.1 |
| Pharmacy sourcing | 15% | 3.4 | 3.1 |
| Cancelling | 15% | 3.7 | 3 |
Coby Health scores higher overall at 3.6 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.
The desk’s call
- Pick Coby Health if cost is the binding constraint. Over a year the gap is about $1,920, which is real money for the same class of medication.
- Pick Willow if what it does better matters to you — a single price with no membership arithmetic.
- Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.
The verdict
On the board, Coby Health at $239 a month is the more defensible choice on arithmetic alone. Willow earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Coby Health and Willow.
How they sit against everyone else
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $149 | $199 | +$50 | +$74/mo |
| Trimi | $125 | $125 | none | — |
| Ozari Health | $125 | $125 | none | — |
| Fifty 410 | $133 | $133 | none | +$8/mo |
| PlexusDx | $129 | $189 | +$60 | +$64/mo |
| Ivím Health | $199 | $199 | none | +$74/mo |
| Zealthy | $216 | $216 | none | +$91/mo |
| Hims & Hers | $199 | $238 | +$39 | +$113/mo |
| Coby Health | $179 | $239 | +$60 | +$114/mo |
| Mochi Health | $199 | $278 | +$79 | +$153/mo |
| Eden | $199 | $298 | +$99 | +$173/mo |
| Lemonaid Health | $229 | $348 | +$119 | +$223/mo |
More from the desk
- Coby Health tirzepatide review
Advertised at $179, billed at $239. Position 9 of 18 on our board.
- Willow tirzepatide review
Advertised at $399 and billed at $399 — no gap. Position 15 of 18 on our board.
- How to spot a bad seller
The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.
- The twelve-month cost
Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
